GeneGo, Inc., a leading provider of software and databases for systems biology, announced that Johnson & Johnson Pharmaceutical Research
& Development, (J&JPRD), a division of Janssen Pharmaceutica N.V., has extended their MetaCore license to now include MetaBase, a database J&JPRD will primarily use for biomarker discovery.
"We are pleased to have this relationship extended," Julie Bryant, Vice President of Business Development at GeneGo said adding, "We look forward to enhancing our collaboration with the MetaBase integration."
GeneGo develops systems biology technology for life science research. The original computational platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, siRNA and other phenotypic data) and relevant bioactive
chemistry within the framework of curated biological pathways and networks.